Examples of 'pegfilgrastim' in a sentence
Meaning of "pegfilgrastim"
Pegfilgrastim (noun) - a prescription medication used to stimulate bone marrow to produce more white blood cells. It is often used in cancer treatment
Show more definitions
- A PEGylated form of filgrastim.
How to use "pegfilgrastim" in a sentence
Basic
Advanced
pegfilgrastim
Pegfilgrastim has not been tested in pregnant women.
Ristempa contains the active substance pegfilgrastim.
Pegfilgrastim is a monomethoxypolyethylene glycol conjugate of filgrastim.
Neulasta contains the active substance pegfilgrastim.
Permanently discontinue pegfilgrastim in patients with clinically significant hypersensitivity.
Neupopeg contains the active substance pegfilgrastim.
Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance.
Ziextenzo contains the active substance pegfilgrastim.
Do not administer pegfilgrastim to patients with a history of hypersensitivity to pegfilgrastim or filgrastim.
Grasustek contains the active substance pegfilgrastim.
Pegfilgrastim is injected subcutaneously.
Fulphila contains the active substance pegfilgrastim.
Pegfilgrastim should be permanently discontinued in patients with clinically significant hypersensitivity.
Pelmeg contains the active substance pegfilgrastim.
Pegfilgrastim should be permanently discontinued in patients who experience a serious allergic reaction.
See also
Pelgraz contains the active substance pegfilgrastim.
Pegfilgrastim should not be administered to patients with a history of hypersensitivity to pegfilgrastim or filgrastim.
Glomerulonephritis has been reported in patients receiving filgrastim or pegfilgrastim.
Pegfilgrastim can also reduce the incidence of infection in patients with some malignancies.
Rates of generation of antibodies against pegfilgrastim is generally low.
Concomitant use of pegfilgrastim with any chemotherapy medicinal product has not been evaluated in patients.
The active substance is pegfilgrastim.
Pegfilgrastim Mundipharma contains the active substance pegfilgrastim.
Glomerulonephritis has been reported in patients receiving filgrastim and pegfilgrastim.
Pegfilgrastim Mundipharma is a biosimilar medicinal product.
Fulphila is a medicine that contains the active substance pegfilgrastim.
Pegfilgrastim Mundipharma has no or negligible effect on the ability to drive or use machines.
Zioxtenzo is a medicine that contains the active substance pegfilgrastim.
Concomitant use of Pegfilgrastim Mundipharma with any chemotherapy agent has not been evaluated in patients.
Loss of response to pegfilgrastim.
An overview of Pegfilgrastim Mundipharma and why it is authorised in the EU.
There are no adequate data from the use of pegfilgrastim in pregnant women.
Sandoz advances its biosimilars program with EMA acceptance of regulatory submission for biosimilar pegfilgrastim.
What Pegfilgrastim Mundipharma is and what it is used for.
Neulasta is a solution for injection that contains the active ingredient pegfilgrastim.
Do not shake Pegfilgrastim Mundipharma vigorously as this may affect its activity.
Neupopeg is a solution for injection that contains the active ingredient pegfilgrastim.
Always use Pegfilgrastim Mundipharma exactly as your doctor has told you.
The adverse events were similar to those in subjects receiving lower doses of pegfilgrastim.
Do not use Pegfilgrastim Mundipharma if.
Associated with a clinical diagnosis of febrile neutropenia was lower in the pegfilgrastim group tn.
After a single subcutaneous dose of pegfilgrastim, the peak serum concentration of pegfilgrastim ed.
Neulasta is a solution for injection that contains the active substance pegfilgrastim.
In rat studies, it was shown that pegfilgrastim may cross the placenta.
Uncommon events of cutaneous vasculitis have been reported in patients treated with pegfilgrastim.
Before administration, pegfilgrastim solution should be inspected visually for particulate matter.
The adverse reactions were similar to those in subjects receiving lower doses of pegfilgrastim.
Pegfilgrastim therapy should be initiated and supervised by physicians experienced in oncology and / or haematology.
UDENYCA contains the active substance pegfilgrastim.
In another embodiment, the hematopoietic agent is pegfilgrastim and the therapeutically effective amount is 6 mg.
